Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.
Wake Forest University Health Sciences
Atara Biotherapeutics
Thomas Jefferson University
Northwestern University
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
University of Chicago
Swiss Cancer Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Morphotek
National Cancer Institute (NCI)
Indiana University
INSYS Therapeutics Inc
Ohio State University Comprehensive Cancer Center
Boston Medical Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Asan Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Vanderbilt-Ingram Cancer Center
Northwestern University
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center